BDSX Biodesix
Biodesix earnings company data as of 4:45 AM ET 11/1
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | -0.75 | — | — |
| Rev | $27.6M | — | — |
Insider trades
Open-market buys and sales by BDSX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $3.1M bought by 1 insider
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Jack W Schuler 10% ownerBuy$367K 15,000 shares at $24.47 +2.8% to stakeTraded Aug 12 Filed Aug 13
-
Jack W Schuler 10% ownerBuy$666K 27,600 shares at $24.13 +5.4% to stakeTraded Aug 10–11 Filed Aug 12
-
Jack W Schuler 10% ownerBuy$1.2M 100,000 shares at $11.81 +6.8% to stakeTraded Jan 23–26 Filed Jan 27
-
Jack W Schuler 10% ownerBuy$904K 82,465 shares at $10.96 +6% to stakeTraded Jan 22 Filed Jan 26
Also filed in the last 12 months, not counted as buying or selling: 24 option exercises and 20 sales to cover taxes.
SEC filings
Recent issuer filings from EDGAR, 18 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 424B3 | Filing Doc | ||
| 8-K | 5.07,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.